H
irsutism is a common endocrine disorder among women of fertile age. 1, 2 Of the vario o ous etiologies of hirsutism, polycystic ovary syndrome (PCOS) is reported to be the commonest cause worldwide. 3, 4 In Saudi Arabia, the prevalence of PCOS is still unknown but it is the authors' belief that it might be similar to other reports. 4 The lack of intero o national consensus on the definition of PCOS prior to the year 2003 accounted for the widely variable prevao o lence in the world. For instance, using ultrasound aco o cording to European criteria, 91% of cases of hirsutism were due to PCOS in the United Arab Emirates 5 yet others reported a rate as low as 59% in the same region. 6 As far as we know, no study has been conducted using the recently approved consensus opinion on diagnoso o tic criteria for diagnosis of PCOS 7 in Saudi patients. Furthermore, there is no study on the pattern of hirsuto o ism in the local population despite it being commonly seen in clinical practice, with its associated infertility and metabolic syndrome. 8, 9 The aim of the study thereo o fore was to determine clinical, biochemical and etiologic
Hirsutism in Saudi females of reproductive age: a hospital-based study

METHODS
We studied a consecutive series of 148 Arab Saudi women presenting with hirsutism to the endocrinolo o ogy clinic at King Khalid University Hospital, Riyadh, Saudi Arabia from 1 January 2000 to 31 December 2005. Patients were examined for the severity of hiro o sutism according to modified Ferriman and Gallwey scale. 10 Women who scored 8 or more were included in the study. Using this scale, we assessed the growth of tero o minal hairs on the upper lip, sideburn area, chest, upper abdomen, and lower abdomen. Acne was also assessed. The presence of comedones on the face, neck, upper chest, upper back, or upper arms was classed as acne. Patients who were taking drugs that might interfere with the results (oral contraceptives, prolactinolowering drugs, and any drug given for hirsutism) and those who failed to report at any scheduled followoup visit were excluded from the study. Other exclusion criteria ino o cluded pregnancy, breastfeeding, known liver or kidney disease, alanine aminotransferase >60 IU/L, creatinine >130 µmol/L, and known alcohol abuse. Only 101 subo o jects were evaluable at the end of the study. The clinical evaluation consisted of a detailed history, including the rapidity of onset of symptoms, the presence of sympo o toms of virilization or other endocrinopathies or metao o bolic disorders, menstrual and reproductive history, and drug and family history. Subjects were assessed for the presence of other signs of hyperandrogenism and virilization and for stigmata of endocrinopathies, and abdominal masses. Height and weight were measured to calculate body mass index (BMI) in kg/m 2 . PCOS was diagnosed based on the presence of 2 out of 3 of the following: 1) oligoo or anovulation and excluo o sion of other etiologies (congenital adrenal hyperplasia, androgen secreting tumors, Cushing' s syndrome), 2) clinical and/or biochemical signs of hyperandrogeno o ism, and 3) polycystic ovaries as recommended by the 2003 consensus diagnostic criteria. 7 Ultrasonographic examinations were performed on average 4 weeks afo o ter the clinical evaluation. Patients were examined in a supine position with a 6oMHz probe, and a polycystic ovary was considered based on presence of 12 or more follicles in each ovary measuring 2o9 mm in diameter, and/or increased ovarian volume (>10 mL) according to the guideline. 7 A regular menstrual cycle was defined as one between 21 and 35 days with no more than a 4oday variation. Oligomenorrhea was defined as meno o strual cycles >35 days in length and amenorrhea was defined as an absence of a menstrual period in more than 6 months. Without the presence of menstrual diso o turbances and any other signs or symptoms of hypero o androgenism, except hirsutism, the diagnosis of idioo o pathic hirsutism (IH) was made. Hyperandrogenemia plus hirsutism (HH) was defined by the presence of elevated androgen levels and hirsutism but normal ovuo o lation. 11 Patients with evidence of ovulatory dysfunco o tion underwent measurements of serum prolactin and thyroidostimulating hormone levels to exclude a prolaco o tin secreting adenoma and thyroid dysfunction, respeco o tively. Screening for Cushing' s syndrome was performed by either an overnight dexamethasone suppression test (i.e. measurement of a cortisol level the morning afo o ter the administration of 1 mg dexamethasone orally at bed time) or by measuring 24 hr urine free cortisol content. All patients had a 2oday laboratory evaluation on days 20o22 of the menstrual cycle (when applicable) in order to characterize ovulatory dysfunction and horo o monal profile in the luteal phase. On day 1 a random blood sample was obtained for total testosterone, ano o drostenedione (A), dehydroepiandrosterone sulphate (DHEAS), prolactin (PRL), progesterone (P), luteinizo o ing hormone (LH), follicle stimulating hormone (FSH), thyroid stimulating hormone (TSH), T3, and T4. 21o hydroxylase deficiency was excluded by a basal follicular phase 17ohydroxyprogesterone (17oOHPG) level <6.0 ng/mL. Subjects with a basal 17oOHPG level equal to or higher than 6.0 ng/mL underwent an acute ACTH stimulation test, in which 250 ug of cortrosyn (alpha 1o24 corticotrophin) was administered and 17oOHPG levels were determined immediately before and again after 30 and 60 minutes. ACTH stimulated 17oOHPG levels >10 ng/mL were considered the criteria for 21o hydroxylase deficient late onset congenital adrenal hyo o perplasia (LOCAH) while values > 30 ng/mL were the criteria for classical congenital adrenal hyperplasia. All statistical procedures were performed using SPSS. Values were reported as mean and standard deviation and when applicable, standard error of the mean. Differences between groups were evaluated with two tailed totests for independent samples or the Manno Whitney zotest, where normality could not be assumed. Pearson correlation coefficients were calculated for coro o relation analyses. Twootailed Povalues <0.05 were cono o sidered significant. Simple linear regression analyses were formed for the investigation of linear trends.
RESULTS
PCOS was the cause of hirsutism in 83 patients (82%) followed by idiopathic hirsutism (IH) with 11 patients (11%) (Figure 1 ). Others causes of hirsutism in our study included lateoonset congenital adrenal hypero o plasia in 4 patients (4%). Of the miscellaneous causes, 2 patients (2%) had microprolactinoma and 1 patient (1%) had Cushing' s syndrome. Of the two major groups identified, PCOS and IH, there were no significant difo o ferences between the groups in terms of age at preseno o tation, distribution of hirsutism, body weight or BMI (Table 1) . Overall, 51% of PCOS and 45% of IH pao o tients were obese. Hirsutism scores were 20.1±7.8 in PCOS and 16.6±6.2 in patients with IH; the differo o ences were not significant (Table 1) . Seventyofour pao o tients (89%) with PCOS had oligo/anovulatory cycle while the remaining 9 patients (11%) maintained noro o mal regular menstrual cycle.
The distribution of BMI among patients with PCOS is shown in Table 2 . Biochemical characteristics of the patients based on etiology are shown in Table 3 .
There were no significant differences between groups for metabolic tests such as fasting blood glucose, 2ohour postoprandial blood glucose and cortisol. As would be expected, LH was higher in the PCOS group compared to the IH group, but the difference was not statistically significant. Furthermore, there was a significant differo o ence in the LHoFSH gradient (serum LH level subo o tracted from serum FSH level) whereby the values were higher for the PCOS patients compared with the other two groups (P<.05). In contrast, IH subjects had sigo o nificantly higher FSH levels when compared to PCOS (P<.05). Total testosterone was found to be significanto o ly higher in PCOS patients compared to IH patients (P<.0.05). Serum levels of progesterone, estradiol, proo o lactin, androstenedione, and DHEAS did not differ beo o tween the two main etiologic groups. According to our diagnostic guideline for LOCAH, 12 four patients met the criteria for 21ohydroxylase deficiency.
DISCUSSION
We have reported our experience evaluating 101 Saudi Arab patients presenting to our endocrine clinic with hirsutism. Of the patients included in the study, 82% had hirsutism caused by PCOS. This is similar to large studies reported by others. 1, 11, 15 However, a close look at our data revealed that 75% of the subjects studied were less than 30 years of age at the time of their initial visit and 51% were obese (BMI ≥30 kg/m 2 ). Thus, the prevo o alence of obesity among our relatively young patients was higher than in the general population. For example, the Saudi National Survey indicated that the prevalence of obesity in women was 44%, 16 a higher prevalence than our PCOS subjects. In population studies, 10% to 38% of women with PCOS were obese. 17o20 Thus, the high prevalence of obesity in our PCOS patients may reflect an overall pattern of obesity in our general female population.
Insulin resistance with compensatory hyperinsuo o linemia has been associated with PCOS and is thought to contribute to other features of the metabolic syno o drome. 9 Hyperandrogenism has been found to manio o fest clinically by frontal balding, acne, hirsutism, and clitoromegaly. In our series, we found that over half of the patients in both PCOS and IH had acne, an obo o servation similar to others. 6 Nevertheless, there were no differences in metabolic data amongst the groups, which was similar to the report by Taponen et al 21 but different from others. 22 This disparity might be due to a higher prevalence of metabolic syndrome in our study population. 23 The prominence of frontal balding in pao o tients with IH as compared to PCOS is not explained. However, it might be due to the small sample size in the IH group. Further studies on a larger population are needed to characterize this finding.
In our series, 9% of patients diagnosed with PCOS had hirsutism in addition to biochemical hyperano o drogenism, yet they maintained a normal menstrual cycle. Azziz et al reported and introduced a new term, hyperandrogenism plus hirsutism (HH), for the cato o egory of hirsute women with normal regular menses that are also hyperandrogenic. 11 The controversy over the disparity between the clinical manifestations of hyo o perandroginism including menstrual irregularity and the metabolic data suggestive of hyperandrogenism was settled in the recently reviewed international consensus on diagnostic criteria for PCOS. 7, 15 Based on the new guideline we included the HH into PCOS. In retroo o spect, Gatee et al reported a higher prevalence of 26% of HH from the same racial group in the neighboring United Arab Emirates. 5 Previously, most hirsute women were labeled as havo o ing 'idiopathic hirsutism' , but up to 60% of these women do have some disturbances in androgen metabolism. 11, 24 Furthermore, more than 90% of patients with IH were proved to have PCOS. 25, 26 Lack of uniformity in agreeo o able guidelines for diagnosis of PCOS might account for the higher figure of IH in older series. 27, 28 In an attempt to unify the diagnosis of PCOS, a joint European and American group came up with a consensus opinion on the diagnostic criteria we used in our study. 7 According to the new guideline, PCOS is diagnosed if two of the following three criteria are present, after the exclusion of other etiologies: 1) oligoo and/or anovulation, 2) clinical and/or biochemical signs of hyperandrogenism, and 3) polycystic ovaries on ultrasonography. 15 Other etiologies of hirsutism were not common in our study group, which is reflected in the observao o tions of others in the region. 5, 6 Of the less common causes, LOCAH was found in 4% of patients, higher than the 1.6% reported in Whites, but lower than the 9.5% reported in patients of Mediterranean descent. 29 The relatively higher prevalence of LOCAH in this study may reflect the pattern of referrals received by our unit, which is a referral center for all of Saudi Arabia, and may differ from the prevalence in the community. However, the overall pattern of PCOS being the como o monest is the same as seen all over the world. 3, 5, 11 Two patients had hyperprolactinemia, which may be part of the syndrome of PCOS. 30 However, these patients lacked the fulloblown picture of PCOS, which includes biochemical hyperandrogenism and one patient did not have menstrual disturbances. Furthermore, the typical polycystic ovaries were lacking. Both were proven on pituitary MRI to have adenoma with a normal thyroid function test and both responded well to bromocripo o tine.
Thus, our data shows that PCOS is the commonest cause of hirsutism in our clinical practice and that it is prominent among young obese females, which reflects the worldwide pattern. Our findings call for an early intervention strategy to prevent or reduce metabolic syndrome in this subgroup of the population. Further prospective studies on a larger scale are needed, howo o ever, to verify our findings.
